Home > Cashflow Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Cash Flow from Investing Activities

    Back to Cashflow Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Investing Activities ₹-12,712 Cr₹-540 Cr₹-168 Cr₹-2,415 Cr₹-197 Cr

What is the latest Cash Flow from Investing Activities ratio of TORRENT PHARMACEUTICALS ?

The latest Cash Flow from Investing Activities ratio of TORRENT PHARMACEUTICALS is ₹-12,712 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Investing Activities
Mar2026₹-12,712 Cr
Mar2025₹-540 Cr
Mar2024₹-168 Cr
Mar2023₹-2,415 Cr
Mar2022₹-197 Cr

How is Cash Flow from Investing Activities of TORRENT PHARMACEUTICALS Trending?

Years Cash Flow from Investing Activities % Change
Mar2026 ₹-12,712 Cr
Negative
Mar2025 ₹-540 Cr
Negative
Mar2024 ₹-168 Cr
Negative
Mar2023 ₹-2,415 Cr
Negative
Mar2022 ₹-197 Cr -

Compare Cash Flow from Investing Activities of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹177,266.4 Cr -2% -6.1% 33% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics
MANKIND PHARMA ₹97,850.4 Cr -4.5% 2.7% -2.1% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-2%

-6.1%

33%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses